2021 has got off to a good start for Demant, both in terms of wholesale and retail sales, the interim management statement covering the year to date released on Tuesday reveals.
Within retail sales, called Hearing Care, France's healthcare reform has boosted figures, while within Hearing Aids – hearing aid wholesale sale – higher sales have been helped by the launch of top product Oticon More, which was launched at the end of November last year.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.